About UsLocationContact UsSite MapHome
Verdier Eye Center
Vision CorrectionSenior Eye HealthClinical StudiesWhy Choose Us?DoctorsTechnologyNewsPatient Forms
   SENIOR TECHNOLOGY
::>> Senior Eye Health Technology
::>> Alcon Acrysof® Foldable Lens
::>> Alcon INFINITI™ System
::>> Corneal Topography
::>> Heidelberg Retina Tomograph
::>> Humphrey® Field Analyzer II
::>> IOLMaster
::>> Optical Coherence Tomography Scanner (OCT)
::>> Toric IOL's
:: SITE LAST UPDATED: 1.18.2012  

Alcon INFINITI™ System

With Alcon's new INFINITI system, cataract surgeons now have three options for removing a cataract: ultrasonic phacoemulsification, ultrasound with oscillation, and liquification.

Ultrasonic phacoemulsification has long been the "gold standard" for cataract surgery. In phacoemulsification surgery, a small ultrasonic probe is inserted into a very small incision on the edge of the eye. This probe gently breaks the cloudy lens into tiny pieces and suctions the cataract out of the eye.

The INFINITI offers a new method that uses both ultrasound and mechanical oscillation to help break up the cataract faster, and may allow the surgeon greater control of lens tissue than traditional ultrasound.

Your doctor may also choose to use a completely new lens removal method, called AquaLase®; Liquefaction. This uses a warm, naturally-balanced solution to safely break up and "wash away" the natural lens.

After the cataract is removed, a folded intra-ocular lens (IOL) is inserted through the micro-incision, then unfolded and locked into permanent position. The small incision is self-sealing and usually requires no stitches. This type of incision heals quickly and provides a much more comfortable recuperation.

Why we've invested in the Alcon INFINITI System:

  • The increased flexibility and multiple removal options provide surgeons with more control over the lens removal procedure.
  • Physicians can choose the method of cataract removal that will most benefit the patient.
  • The new technology may reduce the risk of thermal burns and other potential complications.

 

 

Meet the Doctors
·  David D. Verdier M.D.
·  Karl J. Siebert, M.D.
·  Ann M. Renucci, M.D.
·  M. P. Chelsky, O.D.
News
·  News
·  Procedure Reduces Need For Reading Glasses
·  Corneal Donor Study
·  Fuchs' Endothelial Corneal Dystrophy Genetics Study
Links
·  We have links to several other sites that may help you
Appointments
· Schedule a consultation with our doctors. Tell us when you would like to visit.
 

VISIT US AT:
1000 East Paris Avenue, Suite 130, Grand Rapids, Michigan 49546

PH: 616-949-2001
EMAIL: di@verdiereyecenter.com

Vision Correction | Senior Eye Health | Clinical Studies | Why Choose Us? | Doctors | Technology | News | Patient Forms
Mojo Interactive Programming, Design and Hosting by Mojo Interactive, © 2002-2012.
Content © 2002-2012 Patient Education Concepts, Inc. Licensed Users Only